Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis

BACKGROUND: Despite improvements in treatment success rates for tuberculosis (TB), current six-month regimen duration remains a challenge for many National TB Programmes, health systems, and patients. There is increasing investment in the development of shortened regimens with a number of candidates...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, G. B., Dowdy, D. W., Bastos, M. L., Zwerling, A., Sweeney, S., Foster, N., Trajman, A., Islam, M. A., Kapiga, S., Sinanovic, E., Knight, G. M., White, R. G., Wells, W. A., Cobelens, F. G., Vassall, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131398/
https://www.ncbi.nlm.nih.gov/pubmed/27905897
http://dx.doi.org/10.1186/s12879-016-2064-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131398/
https://www.ncbi.nlm.nih.gov/pubmed/27905897
http://dx.doi.org/10.1186/s12879-016-2064-3

Ejemplares similares